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Background

Conclusion

Glioblastoma is the most common primary adult brain tumor. Surgery
followed by radiation therapy in combination with temozolomide
(Tmz) produces a median survival of 14.6 months. Tmz is a DNA
akylating agent that leads to the mispairing of guanine residues
with thymine. An intact mismatch-repair mechanism (MMR)
converts the mispaired thymine into a lethal double-strand DNA
break. Vorinostat (SAHA), an HDAC inhibitor, has been shown to
act as a radiosensitizer, possibly through inhibition of DNA repair.
SAHA has successfully been combined with a number of cytotoxic
agents. We hypothesized that SAHA would further potentiate the
radiosensitizing properties of Tmz in glioblastoma.

Both Tmz and SAHA individually potentiated the effect of IR,
inhibiting the repair of DNA double strand breaks. However, when
cells were exposed to both drugs together less DNA damage was seen
than with Tmz alone. Based upon qPCR data we hypothesize that
SAHA down regulates the MMR pathway. Our work demonstrates
that the addition of an HDAC inhibitor to cytotoxic agents may
produce unexpected antagonism.
Research sponsored by Merck.

Materials/Methods
Experiments were performed with 2 glioblastoma cell lines (U87,
LN18). DNA double strand breaks were quantified by both neutral
comet assay and gamma-H2AX immunohistochemistry. Assays
were performed immediately, and 24 hours after IR to assess DNA
damage and repair respectively. For the neutral comet assay the
dose of radiation was 30 Gy and the ‘olive moment’ was scored.
The magnitude of the olive moment correlates with increasing
DNA damage. For gamma-H2AX assay, the dose of radiation was
2 Gy and the percentage of cells with more than 3 foci was scored.
Quantitative PCR and clonogenic cell survival were performed using
standard techniques.

Results
In the absence of drug, radiation induced DNA-double strand breaks
were almost completely repaired within 24-hours. In U87 both Tmz +
IR, and SAHA + IR increased the olive moment compared to IR alone
(24 hour post IR time-point). When Tmz and SAHA were combined
together with IR, the olive moment decreased to 6.5 as compared to
Tmz + IR alone 8.7 (p<0.05). Similarly, in the absence of IR, SAHA
was found to decrease Tmz induced DNA damage. Comparable
results were obtained with gamma-H2AX assay and with the LN18
cell line. Clonogenic radiation survival assay demonstrated Tmz +
SAHA to be no more effective than Tmz alone in potentiating the
cytotoxic effect of IR. On qPCR, SAHA was found to down-regulate
MLH1, MLH3, MSH2 and MSH 3, key genes involved in MMR.
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